Fig. 1From: Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemiaChanges in insulin and glucose levels during the OGTT at the three different time points. P-values are by Mann-Whitney U-testBack to article page